News | June 19, 2009

ASTRO to Honor Drs. Lawrence, Shipley with Gold Medal at November Meeting

Theodore Lawrence, M.D., Ph.D., FASTRO

William Shipley, M.D., FASTRO

June 19, 2009 - The American Society for Radiation Oncology (ASTRO) has selected Theodore Lawrence, M.D., Ph.D., FASTRO, and William Shipley, M.D., FASTRO, as its 2009 Gold Medal recipients, the highest honor that ASTRO bestows. Dr. Lawrence and Dr. Shipley will be presented with their awards at the Gold Medal Ceremony being held November 3, 2009, at 10:45 a.m. during ASTRO's 51st Annual Meeting in Chicago.

"Dr. Lawrence and Dr. Shipley have been outstanding contributors to the Society and to the field of radiation oncology as a whole," said Patricia Eifel, M.D., FASTRO, ASTRO chairman. "It is an honor and a personal pleasure for me to be able to present them with the Gold Medal this year in recognition of their distinguished careers and dedication to the specialty."

Dr. Lawrence is an Isadore Lampe professor of radiation oncology, chair of the Department of Radiation Oncology and a professor in the Department of Environmental Health, School of Public Health at the University of Michigan in Ann Arbor, Mich.

On a national level, Dr. Lawrence is the chair of the National Cancer Institute Board of Scientific Councilors and a member of the Institute of Medicine. He is also the editor of Translational Oncology, an editor of The Cancer Journal: Journal of the Principles and Practice of Oncology, and the associate editor of Seminars in Radiation Oncology. Dr. Lawrence is an ASTRO past president and former chairman of the Board, and a past member of the ASCO board of directors. He was also named by the ASTRO Board of Directors as one of the first general co-chairs of the of the Radiation Oncology Institute's Vision of Value fundraising campaign, which will raise money to help develop innovative ways of enhancing the profile of radiation oncology in the world cancer community and prepare the specialty for the future. His interests in the laboratory are focused on chemotherapeutic and molecularly targeted radiosensitizers, and his clinical research combines these laboratory studies with conformal radiation guided by metabolic and functional imaging for the treatment of patients with gastrointestinal and central nervous system malignancies.

Dr. Shipley is chair of the genitourinary oncology unit at Massachusetts General Hospital and the Andres Soriano professor of radiation oncology at Harvard Medical School, both in Boston.

Dr. Shipley is very active in medical societies both in the United States and abroad and has held committee appointments with several of these organizations, including the International Congress of Radiation Oncology, the International Society of Radiation Oncology, the National Bladder Cancer Group and the Radiation Therapy Oncology Group, among many others. Dr. Shipley has authored and co-authored over 160 medical reports, three text books on genitourinary oncology and more than 140 book chapters. He was named a fellow of the American College of Radiology in 1988 and an ASTRO Fellow in 2006.

Dr. Shipley has been actively involved with ASTRO's International Education Subcommittee since 2003, and in 2006, organized the first ASTRO-led international scientific and educational meeting in the Philippines, which was designed to help strengthen ASTRO's involvement in radiation oncology abroad and collaborate with related specialty societies in other countries. ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.

For more information: www.astro.org

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init